Alzheimer's Disease

Alzheimer’s is a Multifactorial Disease; The Genetic and Biochemical Basis of Alzheimer’s Disease; Alzheimer’s Disease Pathology: A Tau Perspective; Structural Insights Into the Amyloidogenic Ab and Tau Species in Alzheimer’s disease Pathophysiology: Defining Functional Motifs for Therapeutic Interventions; Structural Insights on Aggregation Species of Ab and Tau, and Their Implications in Alzheimer’s Disease; Aggregation Species of Amyloid-b and Tau Oligomers in Alzheimer’s Disease: Role in Therapeutics and Diagnostics; Role of Metal Ions in Alzheimer’s Disease: Mechanistic Aspects Contributing to Neurotoxicity; Microglial Blockade of the Amyloid Cascade: A New Therapeutic Frontier; Post-translational Modifications and Alzheimer’s Disease; Autophagy: Role in Alzheimer’s Disease Pathophysiology and Therapeutic Avenues; Transmission of Pathogenic Proteins and the Role of Microbial Infection in Alzheimer’s Disease Pathology; The Role of Gut Microbiome in Alzheimer’s Disease and Therapeutic Strategies; Molecular Probes for the Diagnosis of Alzheimer’s Disease with Implications for Multiplexed and Multimodal Strategies; Circulating Biomarkers for the Diagnosis of Alzheimer’s Disease; Lactoferrin: A Potential Theranostic Candidate for Alzheimer’s Disease; Multifunctional Inhibitors of Multifaceted Ab Toxicity of Alzheimer’s Disease; Tau-targeting Therapeutic Strategies for Alzheimer’s Disease; Computational Development of Alzheimer’s Therapeutics and Diagnostics; Targeted Protein Degradation as a Therapeutic Avenue for Alzheimer’s Disease; Cell-based Therapy for Alzheimer’s Disease; Experimental Models to Study Alzheimer’s Disease; Ethnic and Racial Differences in The Pathophysiology of Alzheimer’s Disease